Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates

Confidential Treatment Applications and SEC Disclosure Guidance

Harvard Law School Forum on Corporate Governance

Brian V. Breheny Andrew J. Brady Caroline S. Kim Ariana M. Taylor

Skadden attorneys review the SEC's Division of Corporation Finance's recently release "CF Disclosure Guidance: Topic No. 7," which addresses confidential treatment requests pursuant to Securities Act Rule 406 and Exchange Act Rule 24b-2.
BACK TO TOP